Chase AIPricingFAQs
Display currency
Loading news…

RenovaCare

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
New York, United States Founded 1983 1-10 employees For Profit

RenovaCare is a biotechnology company focused on developing first-of-their-kind autologous (self-donated) stem cell therapies.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
4
Ticker
RCAR
OTCQB
Patents
0
2 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
RCAR
Exchange
OTCQB
IPO date
Sep 22, 2004

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
1
Active products
20
Patents granted
0
Trademarks
2
IT spend
$16.35K

Company Info

Founded
1983
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
19
HQ
New York, United States
Region
Greater New York Area, East Coast, Northeastern US
Exit date
Sep 22, 2004

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
0
Trend (30d)
0
Trend (90d)
-0.3
Last leadership hire
Jun 10, 2020
4
professional contacts at RenovaCare
Contact execs at RenovaCare

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to RenovaCare

Loading news…

FAQs about RenovaCare

People who checked this page also checked these

Browse the full Acquirezy directory.
RenovaCare - Company Profile, Full Acquisitions List, Funding and Investments